Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

0.7057
Delayed Data
As of 1:23pm ET
 -0.0143 / -1.99%
Today’s Change
0.40
Today|||52-Week Range
3.47
-34.66%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues3.2M5.9M5.9M7.6M
 
 
 
 
 
Cost of Goods Sold2.8M5.2M4.2M5.5M
 
 
 
 
 
Depreciation And Amortization604.4K649.9K638.7K793.8K
 
 
 
 
 
 
Operating ExpensesGross Income-268.4K-8.4K1.0M1.3M
 
 
 
 
 
General Expenses17.8M16.3M11.4M8.1M
 
 
 
 
 
Research And Development6.8M7.6M6.3M3.2M
 
 
 
 
 
Total Operating Expenses21.3M22.1M16.3M14.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.1M-16.3M-10.4M-6.8M
 
 
 
 
 
Extraordinary Credit--5.4M0.00--
 
 
Extraordinary Charge-550.0K-9.4M-420.0K-52.9M
 
 
 
 
 
Interest Expense On Debt551.0K547.3K553.0K477.0K
 
 
 
 
 
Other Expenses4.0K4.8K9.8K13.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.2M-20.9M-11.3M-46.9M
 
 
 
 
 
Income Taxes-46.6K-3.7M-46.6K-13.6M
 
 
 
 
 
Minority Interest-44.6K-31.8K-16.9K-31.0K
 
 
 
 
 
Net Income-19.2M-17.1M-11.4M-33.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.6M44.6M55.2M56.1M
 
 
 
 
 
Shares To Calculate EPS Diluted37.6M44.6M55.2M56.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.38-$0.21-$0.59
 
 
 
 
 
EPS Diluted-$0.51-$0.38-$0.21-$0.59